Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
about
Nephrological and obstetric complications of the antiphospholipid syndromeE-Selectin mediates pathogenic effects of antiphospholipid antibodies.Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis.Prevention of murine antiphospholipid syndrome by BAFF blockadeNew therapeutic targets for the antiphospholipid syndrome.Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus ErythematosusPathophysiology of the antiphospholipid antibody syndrome.Antiphospholipid syndrome: multiple mechanisms.The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse modelIs there a microangiopathic antiphospholipid syndrome?'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?Current knowledge regarding Asherson's syndrome.The use of heparin for preventing miscarriage.Anti-β2-glycoprotein I antibodies.The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.Clinical characteristics of stroke patients with antiphospholipid antibodies.Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus.Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?Antibody specificity and related clinical features in antiphospholipid syndrome.Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss.Pathogenesis of Antiphospholipid Syndrome.Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment
P2860
Q28193094-2B64C906-E3B0-44E4-BD5A-25C343C73700Q33349081-7373C485-9E21-4BFE-A6D9-CB840213CBDBQ33374901-FD0E08E4-7556-437B-A125-F48450949D4CQ33380975-5CAA3AE8-DFF4-47DB-8DA7-868BAA5C5EC4Q34140319-DE254F5D-EB5E-4DF3-8BD0-6476DE31E66FQ34503053-7B5341E7-5E1D-4B7A-B7C9-2616597C2FE2Q35309024-647AFBE4-9B68-4C41-8681-CB291A8541BFQ35775322-1737271F-680F-428E-98B5-21A212CD1147Q35818105-C2E89D67-B286-4C21-B38E-C923ECFDBBC3Q36300619-6B8BE3E8-A623-47BB-B82D-F26227706505Q36759849-DBF59338-47B3-4393-B494-1ED63ECD845FQ37159985-9AA6C794-68FC-4DB1-97C4-00391153C066Q37721617-DC82C15D-F747-4B62-AE6E-4FC1CA544D7DQ37755290-25F26381-76EE-4EC9-806A-37BEAE670888Q37995711-3D0EC8DE-7026-4349-917E-34DC1002FBBDQ38108396-397EC82E-6F56-49BD-98D5-120A24E94C6AQ40282917-799366C4-74E9-4B87-A404-D71B6C8278D9Q43633055-E9E88F0C-D7FB-4EC8-B035-D004A0310189Q43837381-AF8F09D0-78A1-42A0-85BA-7CCF4B279E74Q44566692-CCE7A2F8-74AF-407C-9786-4767949E4087Q45141249-90142D96-9E88-4A2C-ABC0-3D3AE35E4500Q46677340-EF81BB67-1722-43FF-A8BB-E5B65D99F7FEQ47702901-AF65F80B-A93C-4C8C-A1F6-C9AF25ADAD43Q52615315-30057561-CC7F-4533-8031-E8C599A70205Q55506942-DE68FAD4-0C63-4781-8DD9-12D805F8FD40Q58421151-F5C50750-41F0-42C9-811D-8A096CA5D0D8
P2860
Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Endothelial activation by aPL: ...... anifestations of the syndrome.
@ast
Endothelial activation by aPL: ...... anifestations of the syndrome.
@en
Endothelial activation by aPL: ...... anifestations of the syndrome.
@nl
type
label
Endothelial activation by aPL: ...... anifestations of the syndrome.
@ast
Endothelial activation by aPL: ...... anifestations of the syndrome.
@en
Endothelial activation by aPL: ...... anifestations of the syndrome.
@nl
prefLabel
Endothelial activation by aPL: ...... anifestations of the syndrome.
@ast
Endothelial activation by aPL: ...... anifestations of the syndrome.
@en
Endothelial activation by aPL: ...... anifestations of the syndrome.
@nl
P2093
P50
P356
P1476
Endothelial activation by aPL: ...... anifestations of the syndrome.
@en
P2093
Balestrieri G
Nicoletti F
P304
P356
10.1006/JAUT.2000.0412
P577
2000-09-01T00:00:00Z